Abstract: In one embodiment, the present application discloses a method of reducing senescence in a mammal by reducing the concentration of non-ferritin iron within the mammal, comprising the administration of a therapeutically effective amount of an iron chelator or an antioxidant, or a pharmaceutically acceptable salt thereof.
Type:
Application
Filed:
August 21, 2015
Publication date:
September 21, 2017
Applicant:
COLLABORATIVE MEDICINAL DEVELOPMENT LLC